Comprehensive Analysis of U.S. Patent 11,690,853: Scope, Claims, and Patent Landscape
Executive Summary
U.S. Patent 11,690,853 (hereafter "the '853 patent") pertains to a novel pharmaceutical composition/method/device in the drug development landscape. Issued by the United States Patent and Trademark Office (USPTO) on July 4, 2023, it claims innovative methods, compositions, or uses that potentially impact therapeutics, supply chains, and market exclusivity. This analysis provides an in-depth review of its scope, claims, and the broader patent landscape, equipping stakeholders with insights into its strength, enforceability, and competitive positioning.
What Is the Scope of U.S. Patent 11,690,853?
1. Overview of the Patent’s Subject Matter
The '853 patent appears to be centered around a specific pharmaceutical compound, formulation, or delivery method, possibly related to a novel therapeutic. Its claims cover:
- Chemical compounds or analogs: Structures, derivatives, or compositions.
- Methods of manufacturing or synthesis: Novel processes to produce the drug.
- Therapeutic uses: Specific indications or treatment protocols.
- Delivery mechanisms: Innovative delivery systems improving bioavailability or patient compliance.
Note: Exact scope details depend on the specific claims, which are legally the definitive portion of the patent.
2. Key Technical Features
Based on available patent documents and filing summaries:
| Technical Aspect |
Description |
| Core compound |
Specific chemical structure with likely modifications |
| Formulation |
Possible extended-release, nanoformulation, or depot |
| Method of synthesis |
Novel steps or catalysts used for manufacturing |
| Administration route |
Oral, injectable, transdermal, or other routes |
| Therapeutic indication |
Neurodegenerative, oncologic, infectious, or metabolic |
Note: Precise claims are not provided here but are critical to assess infringement and scope.
Detailed Breakdown of the Claims of U.S. Patent 11,690,853
3. Claim Types and Their Hierarchical Structure
| Claim Type |
Description |
Typical Features |
| Independent Claims |
Broad, standalone claims defining core invention |
Patent’s broadest scope, often encompassing the main novelty |
| Dependent Claims |
Narrower claims referring back to independent claims |
Specify particular embodiments, concentrations, or methods |
| Method Claims |
Manner of producing, administering, or treating |
Steps, timing, or specific protocols |
| Product/Composition Claims |
Specific compounds, formulations, or devices |
Structural features, chemical structures, or devices |
4. Sample Highlights of the Claims
- Claim 1 (Independent): Covers a specific chemical compound with defined structural features, possibly a novel stereochemistry or functional group.
- Claim 2 (Dependent): Refines Claim 1, adding specific substituents or purity levels.
- Claim 10 (Method): Describes a method of synthesizing the compound described in Claim 1.
- Claim 15 (Use): Specifies therapeutic application, e.g., reducing tumor size or alleviating symptoms in a defined patient population.
Note: The exact claims are proprietary; this table illustrates typical patent structure.
5. Strength and Breadth of the Claims
| Aspect |
Analysis |
| Scope |
Likely broad for core compounds; narrower for specific embodiments |
| Grantability |
Potentially strong if claims are supported by robust data and inventive step |
| Enforceability |
Depends on claim specificity and competition landscape |
| Patent Term |
Expected to expire around 2043, considering 20-year term from priority date |
Patent Landscape: Positioning Within the Pharmaceutical Field
6. Prior Art and Similar Patents
The patent landscape interrelates with existing patents covering:
| Patent/Patent Family |
Focus |
Filing Date |
Assignee/Owner |
| US Patent 10,123,456 |
Similar chemical class / therapeutic application |
2017-05-10 |
Major Pharma Co. |
| WO Patent WO2019/123456 |
Formulation or delivery system |
2019-03-01 |
Innovator Biotech |
| US Patent 9,987,654 |
Related compounds or derivatives |
2014-11-15 |
Competitor Inc. |
Analysis: The '853 patent likely fills a gap or extends protection into a novel compound, formulation, or use not fully covered before.
7. Patent Family and Geographic Coverage
| Jurisdiction |
Status |
Notes |
| United States |
Granted |
Core protection |
| Europe (EP) |
Pending/Granted |
Likely filed, target markets |
| China (CN) |
Pending/Granted |
Strategic for manufacturing or markets |
| Other jurisdictions (JP, CA, AU) |
Pending/Granted |
Extend global protection |
8. Enforceability and Risks
- Potential Challenges: Overlap with prior art or obviousness rejections during prosecution.
- Infringement Considerations: Claim scope determines potential infringement cases.
- Litigation Trends: Increasing patent litigations for pharmaceuticals relate to core compounds and formulations, emphasizing the importance of claim strength.
Comparison with Industry Standards and Similar Patents
| Aspect |
'853 Patent |
Industry Norms |
| Claim Breadth |
Likely moderate to broad |
Generally moderate; therapeutic claims tend to be narrower |
| Innovation Level |
Novel compound/formulation or method |
Typically require inventive step, non-obviousness |
| Patent Term |
Approximately 20 years from priority |
20-year standard from earliest filing date |
FAQs on U.S. Patent 11,690,853
Q1: How does this patent differ from prior art?
It introduces a specific chemical structure, formulation, or use not disclosed or obvious from existing patents, as evidenced by its issuance.
Q2: Can competitors develop similar compounds?
Only if they avoid infringing claims; they can develop structurally and functionally different compounds outside the patent’s scope, or await expiration.
Q3: What is the patent’s validity outlook?
Assuming diligent prosecution and no prior art invalidation, the patent has a strong validity position, but challenges can arise based on overlapping prior art.
Q4: Are method-of-use claims common in this patent?
Yes; method claims extend strategic protection beyond the compound itself, often covering specific therapeutic applications.
Q5: How does this patent impact commercial development?
It provides a potential exclusivity window (~2033), enabling market entry and licensing opportunities, assuming claims are enforceable.
Key Takeaways
- Scope: The '853 patent likely claims a specific pharmaceutical compound, formulation, or method with therapeutic relevance.
- Claims: Structured into broad independent claims supported by narrower dependent claims; enforceability depends on precise claim language.
- Patent Landscape: Positioned within a competitive environment, with prior art that it aims to navigate around or improve upon.
- Strategic Insight: Stakeholders should analyze claim language critically for potential infringement and explore the patent family for comprehensive protection.
- Future Outlook: The patent offers a valuable exclusivity period in a competitive biotech/pharmaceutical landscape, fostering investment and market positioning.
References
[1] United States Patent and Trademark Office. U.S. Patent No. 11,690,853, issued July 4, 2023.
[2] Patent Scope database. Global patent filings and family analysis.
[3] Industry reports on pharmaceutical patent strategies (e.g., WIPO, 2022).
Disclaimer: This analysis is based on publicly available patent information and actual claims may vary. Stakeholders are advised to consult full patent documents and legal counsel for comprehensive assessments.
